Skip to main content
. 2022 Feb 16;13(2):156. doi: 10.1038/s41419-022-04602-5

Fig. 6. Yme1L and OMA1 are responsible for degrading CHCHD2 and CHCHD10.

Fig. 6

A Immunoblot of OMA1 KO, Yme1L KO, OMA1 Yme1L DKO, and WT HeLa cells treated with dimethyl sulfoxide (DMSO) or 10 μm Oligomycin for 8 h. GAPDH served as loading controls. B Immunoblot of WT and CHCHD2 KO HeLa cell lines which stably express CHCHD2 WT, T61I or R145Q mutation where indicated, treated with either vehicle or 125 μm Oligomycin for 6 h. GAPDH served as the loading control. C Quantification of levels CHCHD2 and its mutation CHCHD2-T61I and CHCHD2-R145Q from B. The relative protein levels were evaluated by densitometry analysis using ImageJ software and were quantified for the ratio of CHCHD2/GAPDH, T61I /GAPDH, and R145Q/GAPDH (n = 3 independent experiments). The data are presented as mean ± SD.